Top Page
Semler Scientific
(NASDAQ:SMLR)
Semler Scientific (SMLR) vs. SPDR S&P 500 ETF (SPY)
Semler Scientific Business Overview & Revenue Model
Semler Scientific Earnings Call Summary
Semler Scientific Financial Statement Overview
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 42.98M | 56.29M | 68.18M | 56.69M | 53.03M | 38.60M |
| Gross Profit | 39.04M | 51.53M | 61.20M | 52.43M | 46.91M | 35.25M |
| EBITDA | -23.00M | 21.51M | 23.28M | 17.79M | 19.45M | 15.96M |
| Net Income | 37.05M | 40.90M | 20.58M | 14.32M | 17.22M | 14.01M |
Balance Sheet | ||||||
| Total Assets | 522.60M | 239.83M | 78.06M | 62.69M | 50.67M | 34.64M |
| Cash, Cash Equivalents and Short-Term Investments | 13.48M | 14.92M | 57.20M | 43.09M | 37.32M | 22.08M |
| Total Debt | 96.25M | 70.00K | 160.00K | 245.00K | 325.00K | 332.00K |
| Total Liabilities | 102.42M | 9.08M | 6.27M | 7.02M | 5.13M | 4.85M |
| Stockholders Equity | 383.41M | 230.75M | 71.80M | 55.68M | 45.55M | 29.79M |
Cash Flow | ||||||
| Free Cash Flow | -117.24M | 24.36M | 20.50M | 15.30M | 15.23M | 14.36M |
| Operating Cash Flow | 12.46M | 24.41M | 21.33M | 17.46M | 16.06M | 15.42M |
| Investing Cash Flow | -366.41M | -189.98M | 18.40M | -26.84M | -825.00K | -1.31M |
| Financing Cash Flow | 360.10M | 117.19M | -5.41M | -4.94M | 13.00K | 230.00K |
Semler Scientific Technical Analysis
Semler Scientific Risk Analysis
Semler Scientific Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | $273.75M | 19.73 | 7.64% | ― | 6.15% | -54.24% | |
64 Neutral | $393.42M | ― | -25.57% | ― | -1.36% | -479.49% | |
61 Neutral | $534.89M | 14.88 | 16.04% | ― | -30.39% | 46.15% | |
61 Neutral | $305.83M | ― | -76.21% | ― | 23.22% | 9.54% | |
54 Neutral | $506.34M | ― | -15.36% | ― | -0.02% | -1196.44% | |
51 Neutral | $7.35B | -0.20 | -44.53% | 2.35% | 30.18% | -1.17% | |
48 Neutral | $403.59M | ― | -102.61% | ― | 5.94% | 25.16% |
Semler Scientific Corporate Events
Semler Scientific has announced updates regarding its financial activities, including a Controlled Equity Offering℠ Sales Agreement entered on April 15, 2025, allowing the company to issue and sell up to $500 million of its common stock. By July 23, 2025, the company had raised approximately $194.3 million through this program. Additionally, Semler Scientific acquired 175 Bitcoin between July 17 and July 23, 2025, using proceeds from the ATM offering, and held a total of 5,021 Bitcoin valued at $594.8 million as of July 23, 2025. The company reported a BTC Yield of 31.3% year-to-date, indicating a strategic focus on enhancing shareholder value through Bitcoin investments.
The most recent analyst rating on (SMLR) stock is a Buy with a $40.00 price target. To see the full list of analyst forecasts on Semler Scientific stock, see the SMLR Stock Forecast page.
Semler Scientific has launched a dashboard on its website to disclose information about its Bitcoin holdings, market data, and related key performance indicators. This initiative aims to ensure compliance with disclosure regulations and provide transparency to investors and stakeholders.
The most recent analyst rating on (SMLR) stock is a Buy with a $40.00 price target. To see the full list of analyst forecasts on Semler Scientific stock, see the SMLR Stock Forecast page.
Semler Scientific has launched a website dashboard to disclose information about its Bitcoin holdings, market data, and key performance indicators to comply with Regulation FD. This initiative aims to provide transparent and broad distribution of material information, encouraging investors to regularly review the updates.
The most recent analyst rating on (SMLR) stock is a Buy with a $40.00 price target. To see the full list of analyst forecasts on Semler Scientific stock, see the SMLR Stock Forecast page.
On June 24, 2025, Semler Scientific announced the creation of CardioVanta, Inc., a wholly-owned subsidiary dedicated to its future healthcare business activities. This strategic move aims to enhance the company’s focus on early detection of heart-related conditions and involves seeking external investment to support its initial capital requirements, potentially impacting its market positioning and stakeholder interests.
The most recent analyst rating on (SMLR) stock is a Buy with a $40.00 price target. To see the full list of analyst forecasts on Semler Scientific stock, see the SMLR Stock Forecast page.
On June 22, 2025, Semler Scientific‘s board of directors approved the Fifth Amended and Restated Bylaws, effective immediately. This amendment was made to clarify compliance with Delaware General Corporation Law and to align with the company’s certificate of incorporation, potentially impacting corporate governance and operational clarity.
The most recent analyst rating on (SMLR) stock is a Buy with a $40.00 price target. To see the full list of analyst forecasts on Semler Scientific stock, see the SMLR Stock Forecast page.
On June 19, 2025, Semler Scientific, Inc. announced the appointment of Joe Burnett as director of Bitcoin strategy. The company also revealed its ambitious plan to acquire 10,000 Bitcoins by the end of 2025, 42,000 by the end of 2026, and 105,000 by the end of 2027, utilizing funds from equity and debt financings as well as cash flows from operations.
The most recent analyst rating on (SMLR) stock is a Buy with a $40.00 price target. To see the full list of analyst forecasts on Semler Scientific stock, see the SMLR Stock Forecast page.
On June 4, 2025, Semler Scientific, Inc.’s board of directors approved and adopted its Fourth Amended and Restated Bylaws to align with the current Delaware General Corporation Law. This update reflects changes such as the removal of the requirement for a stockholder list during meetings and the elimination of restrictions on actions without meetings, potentially streamlining corporate governance processes.
The most recent analyst rating on (SMLR) stock is a Buy with a $71.00 price target. To see the full list of analyst forecasts on Semler Scientific stock, see the SMLR Stock Forecast page.
Semler Scientific has established a dashboard on its website to disclose information about its Bitcoin holdings and related financial metrics, aiming to provide transparency and comply with regulatory obligations. Between May 23 and June 3, 2025, the company acquired 185 Bitcoin for $20 million, bringing its total holdings to 4,449 Bitcoin, valued at $472.9 million, and reported a BTC Yield of 26.7% year-to-date, reflecting its strategy to enhance shareholder value through Bitcoin investments.
The most recent analyst rating on (SMLR) stock is a Buy with a $40.00 price target. To see the full list of analyst forecasts on Semler Scientific stock, see the SMLR Stock Forecast page.
Semler Scientific announced its recent financial activities, including an at-the-market offering program initiated on April 15, 2025, allowing the company to issue and sell up to $500 million of its common stock. By May 22, 2025, the company had raised approximately $114.8 million through this program. Additionally, between May 13 and May 22, 2025, Semler Scientific acquired 455 Bitcoin for $50 million, bringing its total Bitcoin holdings to 4,264, valued at $474.4 million as of May 22, 2025. The company reported a BTC Yield of 25.8% year-to-date, which it uses as a key performance indicator to evaluate the effectiveness of its Bitcoin acquisition strategy.
The most recent analyst rating on (SMLR) stock is a Buy with a $71.00 price target. To see the full list of analyst forecasts on Semler Scientific stock, see the SMLR Stock Forecast page.
On May 15, 2025, Semler Scientific‘s Board of Directors appointed Ms. Natalie Brunell to fill a vacancy in Class II, effective immediately, and to serve on the Bitcoin Strategy Committee. Ms. Brunell received stock options as part of her compensation, and Semler Scientific entered into a standard indemnification agreement with her, ensuring protection against certain legal expenses.
The most recent analyst rating on (SMLR) stock is a Buy with a $40.00 price target. To see the full list of analyst forecasts on Semler Scientific stock, see the SMLR Stock Forecast page.